Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-15 Sale |
2024-11-19 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
15 | $478.56 | $7,178 | 25,813 (Direct) |
View |
| 2024-11-11 Sale |
2024-11-13 4:15 pm |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
3,000 | $518.27 | $1,554,810 | 44,137 (Direct) |
View |
| 2024-11-08 Sale |
2024-11-12 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
15,198 | $515 | $7,826,970 | 75,772 (Direct) |
View |
| 2024-10-02 Sale |
2024-10-03 4:12 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer |
999 | $461.66 | $461,198 | 16,651 (Direct) |
View |
| 2024-08-30 Sale |
2024-09-04 4:13 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
3,784 | $499 | $1,888,216 | 10,434 (Indirect Direct) |
View |
| 2024-08-30 Sale |
2024-09-04 4:12 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
646 | $500 | $323,000 | 4,435 (Direct) |
View |
| 2024-08-08 Sale |
2024-08-12 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
1,292 | $466.29 | $602,447 | 5,081 (Direct) |
View |
| 2024-08-07 Sale |
2024-08-08 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
2,280 | $476.75 | $1,086,990 | 23,259 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-02 4:10 pm |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
5,295 | $508 | $2,689,860 | 40,000 (Direct) |
View |
| 2024-07-30 Sale |
2024-08-01 4:17 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
15,202 | $505 | $7,677,010 | 90,970 (Direct) |
View |
| 2024-07-24 Sale |
2024-07-25 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
2,280 | $488.46 | $1,113,689 | 25,539 (Direct) |
View |
| 2024-07-22 Sale |
2024-07-24 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
15,202 | $497 | $7,555,394 | 106,172 (Direct) |
View |
| 2024-07-10 Sale |
2024-07-12 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
2,280 | $487.34 | $1,111,135 | 27,819 (Direct) |
View |
| 2024-06-26 Sale |
2024-06-28 4:04 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
2,280 | $471.72 | $1,075,522 | 30,099 (Direct) |
View |
| 2024-06-12 Sale |
2024-06-13 4:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
2,280 | $478 | $1,089,840 | 32,379 (Direct) |
View |
| 2024-06-12 Sale |
2024-06-13 4:09 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
7,288 | $478 | $3,483,664 | 15,972 (Direct) |
View |
| 2024-06-03 Sale |
2024-06-05 4:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
3,250 | $460 | $1,495,000 | 47,137 (Direct) |
View |
| 2024-06-03 Sale |
2024-06-05 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,175 | $460 | $1,000,500 | 49,098 (Direct) |
View |
| 2024-05-30 Sale |
2024-06-03 4:09 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
4,600 | $441.99 | $2,033,159 | 51,273 (Direct) |
View |
| 2024-05-29 Sale |
2024-05-31 4:19 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
2,280 | $445.56 | $1,015,877 | 34,659 (Direct) |
View |
| 2024-05-28 Sale |
2024-05-30 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
3,250 | $454.79 | $1,478,068 | 50,387 (Direct) |
View |
| 2024-05-24 Sale |
2024-05-29 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
1,565 | $457 | $715,205 | 121,374 (Direct) |
View |
| 2024-05-22 Sale |
2024-05-24 4:13 pm |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
7,073 | $448 | $3,168,704 | 40,000 (Direct) |
View |
| 2024-05-20 Sale |
2024-05-22 4:21 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
15,202 | $447 | $6,795,294 | 121,374 (Direct) |
View |
| 2024-05-15 Sale |
2024-05-17 4:27 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
32 | $430.93 | $13,790 | 62,772 (Indirect Direct) |
View |
| 2024-05-15 Sale |
2024-05-17 4:24 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
69 | $430.93 | $29,734 | 49,831 (Indirect Direct) |
View |
| 2024-05-15 Sale |
2024-05-17 4:22 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
54 | $430.93 | $23,270 | 25,813 (Direct) |
View |
| 2024-05-01 Sale |
2024-05-03 4:26 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director |
1,168 | $0 | $0 | 3,962 (Direct) |
View |
| 2024-05-01 Sale |
2024-05-03 4:18 pm |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
1,168 | $0 | $0 | 8,633 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-04 Option Award |
2025-02-06 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
19,428 | $0 | 45,241 (Direct) |
View |
| 2025-01-15 Option Award |
2025-01-17 4:04 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
112 | $420.31 | 15,145 (Direct) |
View |
| 2024-10-15 Option Award |
2024-10-17 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
90 | $484.39 | 15,033 (Direct) |
View |
| 2024-10-01 Tax Withholding |
2024-10-03 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer |
630 | $466.84 | 16,651 (Direct) |
View |
| 2024-08-30 Exercise |
2024-09-04 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
646 | $152.74 | 4,435 (Direct) |
View |
| 2024-08-30 Exercise |
2024-09-04 4:12 pm |
N/A 2028-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
646 | $0 | 4,435 (Direct) |
View |
| 2024-08-08 Exercise |
2024-08-12 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
1,292 | $152.74 | 5,081 (Direct) |
View |
| 2024-08-08 Exercise |
2024-08-12 4:08 pm |
N/A 2028-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
1,292 | $0 | 5,081 (Direct) |
View |
| 2024-08-01 Exercise |
2024-08-02 4:10 pm |
N/A 2027-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
5,295 | $0 | 40,000 (Direct) |
View |
| 2024-08-01 Exercise |
2024-08-02 4:10 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
5,295 | $125.71 | 40,000 (Direct) |
View |
| 2024-07-15 Option Award |
2024-07-17 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
89 | $490.12 | 14,943 (Direct) |
View |
| 2024-06-11 Tax Withholding |
2024-06-13 4:09 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
6,824 | $481.96 | 15,972 (Direct) |
View |
| 2024-06-05 Gift |
2024-06-07 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
4,600 | $0 | 58,172 (Indirect) |
View |
| 2024-05-24 Exercise |
2024-05-29 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
1,565 | $187.53 | 121,374 (Direct) |
View |
| 2024-05-24 Exercise |
2024-05-29 4:08 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
1,565 | $0 | 121,374 (Direct) |
View |
| 2024-05-22 Exercise |
2024-05-24 4:13 pm |
N/A 2026-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
7,073 | $0 | 40,000 (Direct) |
View |
| 2024-05-22 Exercise |
2024-05-24 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
7,073 | $93.51 | 40,000 (Direct) |
View |
| 2024-05-15 Option Award |
2024-05-17 4:18 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Schneider Jennifer Director |
922 | $0 | 922 (Direct) |
View |
| 2024-05-14 Option Award |
2024-05-16 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
14,112 | $0 | 30,084 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 4:26 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director |
2,169 | $0 | 3,962 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 4:23 pm |
N/A 2034-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | Thornberry Nancy Director |
2,072 | $0 | 3,208 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 4:21 pm |
N/A 2034-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
3,142 | $0 | 3,142 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 4:18 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
2,169 | $0 | 8,633 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 4:16 pm |
N/A 2034-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | Lagarde Michel Director |
3,142 | $0 | 3,142 (Direct) |
View |